Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the first sales of its asthma diagnostic Aridol® (mannitol bronchial challenge test) in the United States following the relaunch of the product.
Proactive Investors Interview with Pharmaxis Ltd CEO Gary Phillips on 23 November 2018.
Chairman's Address by Malcolm McComas to the 2018 Annual General Meeting
Presentation by the Pharmaxis CEO and CFO to the 2018 AGM
Presentations from the Investor Research Briefing held on 20 November 2018.